Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Invested Capital (2023 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Return on Invested Capital for 3 consecutive years, with 0.31% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Return on Invested Capital rose 4.0% year-over-year to 0.31%, compared with a TTM value of 0.31% through Jun 2025, up 4.0%, and an annual FY2024 reading of 0.37%, down 9.0% over the prior year.
  • Return on Invested Capital was 0.31% for Q2 2025 at Arcturus Therapeutics Holdings, up from 0.34% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.21% in Q3 2023 and bottomed at 0.46% in Q1 2024.
  • Average Return on Invested Capital over 3 years is 0.28%, with a median of 0.33% recorded in 2025.
  • The sharpest move saw Return on Invested Capital plummeted -52bps in 2024, then increased 12bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.3% in 2023, then dropped by -28bps to 0.38% in 2024, then grew by 18bps to 0.31% in 2025.
  • Business Quant data shows Return on Invested Capital for ARCT at 0.31% in Q2 2025, 0.34% in Q1 2025, and 0.38% in Q4 2024.